Eisen A, Schulzer M, MacNeil M, Pant B, Mak E
Neuromuscular Diseases Unit, University of British Columbia, Vancouver, Canada.
Muscle Nerve. 1993 Jan;16(1):27-32. doi: 10.1002/mus.880160107.
Since 1985, we prospectively followed 246 patients with ALS. The relationship between the age of developing neurological impairment and disease duration was analyzed in 138 patients (86 men and 52 women) who died. Mean disease duration was 4.0 +/- 3.8 years for men and 3.2 +/- 2.5 years for women. There was an inverse, exponential, relationship between onset age and duration (goodness-of-fit P > 0.05). Mean duration at onset age < or = 40 years was 8.2 +/- 5.0 years compared with 2.6 +/- 1.4 years for patients aged 61 to 70 years (P > 0.001). The ratio of young (< or = 40 years) men to women was 3.6:1. When matched for age, disease duration was the same for patients with bulbar and nonbulbar onsets. We conclude that onset age, but not sex, is the most significant predictor determining disease duration in ALS. Longer survival in younger patients probably reflects their greater neuronal reserve.
自1985年以来,我们对246例肌萎缩侧索硬化症(ALS)患者进行了前瞻性随访。在138例死亡患者(86例男性和52例女性)中分析了出现神经功能障碍的年龄与疾病持续时间之间的关系。男性的平均疾病持续时间为4.0±3.8年,女性为3.2±2.5年。发病年龄与疾病持续时间呈负指数关系(拟合优度P>0.05)。发病年龄≤40岁患者的平均疾病持续时间为8.2±5.0年,而61至70岁患者为2.6±1.4年(P>0.001)。年轻(≤40岁)男性与女性的比例为3.6:1。当按年龄匹配时,延髓起病和非延髓起病患者的疾病持续时间相同。我们得出结论,发病年龄而非性别是决定ALS疾病持续时间的最重要预测因素。年轻患者生存期较长可能反映了他们更大的神经储备。